Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
Crossref DOI link: https://doi.org/10.1007/s11684-021-0835-8
Published Online: 2021-08-31
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Sisi
Peng, Lijun
Xu, Wenqian
Zhou, Yuebo
Zhu, Ziyan
Kong, Yushan
Leung, Stewart
Wang, Jin
Yan, Xiaoqiang
Mi, Jian-Qing
Text and Data Mining valid from 2021-08-31
Version of Record valid from 2021-08-31
Article History
Received: 19 August 2020
Accepted: 9 November 2020
First Online: 31 August 2021